New drugs and vaccines for priority pathogens in antimicrobial resistance 2019

Basic Information

Antimicrobials are designed to kill or stop the growth of disease-causing pathogens, but many of them have become increasingly ineffective due to emerging resistance by the targeted bacteria, viruses, protozoa or fungi. Selection pressure naturally leads to the emergence of resistance whenever microbes are exposed to agents who are meant to kill them or inhibit their growth, and the potential spreading resistance can take days or years. Pathogens can also develop resistance to multiple agents, and as a result, very hard to control multi-drug resistant infections emerge and spread.

Network EDCTP2
Aim of the joint call The purpose of this call for proposals is to provide funding for clinical trials to be conducted in sub-Saharan Africa which aim to develop new or improved medicinal products (drugs and vaccines) or combinations thereof against pathogens from the WHO priority list that also fall within the scope of the EDCTP2 programme, specifically Campylobacter, Salmonella, Streptococcus pneumoniae, and Mycobacterium tuberculosis.
Type of joint call One Stage - Call with no pre-proposals submission
Launch date 03/06/2019
Deadline Full-Proposal 07/11/2019 Submitted proposal: n/a
Evaluation End Date n/a Successful proposal: n/a Proposals funded: n/a
Is call co-funded? No
Call follow up funding n/a
Call reasons n/a
Research fields
  • Health
Type of research n/a
Target groups n/a
Participating networks n/a

Organisations Participating

No participating organisations found.